EpCAM is a type I glycosylated membrane protein expressed at low levels in a variety of human epithelial tissues, but overexpressed in most solid cancers, including prostate cancer [36] and most of the studies reported to date use EpCAM as the target marker to identify potential CTCs. The gene discussed is EPCAM; the disease is Familial prostate cancer.